NCT04880889View on ClinicalTrials.gov

BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

PHASE3UnknownINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2023

Conditions
Telogen Effluvium
Interventions
DRUG

BL 3000

capsule 500 mg

DRUG

Reference Pantogar

capsule

DRUG

BL3000 Placebo

capsule 500 mg

DRUG

Pantogar - Placebo

capsule

Sponsors
All Listed Sponsors
lead

Biolab Sanus Farmaceutica

INDUSTRY